News
Major breakthrough of Sanyou Biopharmaceuticals AI-STAL
13+ hour, 35+ min ago (832+ words) SHANGHAI, May 18, 2026 /PRNewswire/ " Sanyou Biopharmaceuticals announced today that its independently developed AI-STAL has undergone a significant upgrade, successfully achieving a qualitative leap from "molecular treasure trove" to "intelligent engine", marking the company's entry into a new era of intelligence in…...
Galux Outperforms Global Rivals in AI Antibody Design Benchmark
3+ hour, 22+ min ago (344+ words) Compared with Global Antibody Design Platform Studies Secures Binding Antibodies for 8 of 9 Common Targets Galux, an artificial intelligence (AI)-based drug discovery company, said Wednesday that its AI protein design platform "Galux Design" delivered the strongest performance when compared with…...
Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts
1+ hour, 4+ min ago (321+ words) Tempus AI Inc. announced a new collaboration initiative with Bristol Myers Squibb Co. aimed at improving clinical trial design and increasing the Probability of Technical & Regulatory Success across five initial development programs. The companies plan to use artificial intelligence, multimodal…...
Scientists discover faster way to build new medicines by swapping atoms in molecules
3+ hour, 36+ min ago (79+ words) ...
Protein Engineering and Testing Condensed into One Day
5+ hour ago (1025+ words) Proteins lie at the heart of biological function and industrial innovation, representing a vast frontier for scientific discovery and application. Engineering proteins to enhance or alter their functionality holds enormous promise for treating disease, advancing cellular therapies, and revolutionizing manufacturing…...
Machine Learning Pinpoints Immunotherapy Targets, Validated by Tumor
5+ hour, 42+ min ago (778+ words) In a groundbreaking advancement at the intersection of artificial intelligence and oncology, researchers have unveiled a pioneering method that harnesses machine learning to accelerate immunotherapy drug target discovery. This multidisciplinary approach not only streamlines the identification of promising therapeutic candidates…...
Sino Biological Launches XPress MAX" Cell-Free Protein Synthesis Kit to Accelerate AI-Driven Antibody Drug Discovery - citybuzz
11+ hour, 45+ min ago (290+ words) Our XPress MAX" is a significant advancement in research tools and reagents for next-generation therapeutic discovery," said Dr. Rob Burgess, Chief Business Officer at Sino Biological US, Inc. By combining rapid, reliable protein expression with intelligent screening, we are helping…...
Big pharma cuts jobs and ramps up AI to brace for patent cliff, Korea lags
5+ hour, 28+ min ago (17+ words) CHOSUNBIZ Chosunbiz...
Sandbox AQ brings its drug discovery models to Claude " no Ph D in computing required
6+ hour ago (108+ words) Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. Sandbox AQ is betting that the bigger obstacle is access, and that Claude solves it....
Code Life AI Annouces a Unified Revolutionary AI platform for DNA, Protein, Cell Design and Simulation
8+ hour, 43+ min ago (311+ words) Code Life AI: The All-in-one AI Biotech Platform Rather than serving as just another point solution, Code Life AI is designed as an AI-native workspace for the full biotechnology research lifecycle. It gives users a single environment where biological ideas…...